Compounds > sq 28603
Page last updated: 2024-09-03

sq 28603 and angiotensin ii

sq 28603 has been researched along with angiotensin ii in 5 studies

Compound Research Comparison

Studies
(sq 28603)		Trials
(sq 28603)		Recent Studies (post-2010)
(sq 28603)		Studies
(angiotensin ii)		Trials
(angiotensin ii)		Recent Studies (post-2010) (angiotensin ii)
350038,1521,0897,413

Protein Interaction Comparison

ProteinTaxonomysq 28603 (IC50)angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3Homo sapiens (human)0.002
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.002
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0018
Type-1 angiotensin II receptorHomo sapiens (human)0.0055
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.004
Type-2 angiotensin II receptorHomo sapiens (human)0.0011

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennett, T; Gardiner, SM; Kemp, PA1
Burnett, JC; Margulies, KB; McKinley, LJ; Perrella, MA1
Fox, M; Panchal, BC; Trippodo, NC1
Allen, GT; Powell, JR; Tesfamariam, B1
Dietz, R; Höhnel, K; Luft, FC; Scheuermann, M; Willenbrock, R1

Other Studies

5 other study(ies) available for sq 28603 and angiotensin ii

ArticleYear
Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1-38] in conscious rats.
    British journal of pharmacology, 1992, Volume: 106, Issue:1

    Topics: Alanine; Angiotensin I; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Endothelin-1; Endothelins; Heart Rate; Injections, Intravenous; Male; Neprilysin; Protein Precursors; Rats

1992
Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.
    The Journal of clinical investigation, 1991, Volume: 88, Issue:5

    Topics: Alanine; Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Heart Failure; Hemodynamics; Kidney; Male; Neprilysin; Sodium

1991
Repression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:2

    Topics: Alanine; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Blood Volume; Bradykinin; Cricetinae; Drug Synergism; Enalaprilat; Heart Failure; Irbesartan; Male; Neprilysin; Tetrazoles; Vasodilation; Ventricular Function, Left

1995
Bradykinin B2 receptor-mediated chronotropic effect of bradykinin in isolated guinea pig atria.
    European journal of pharmacology, 1995, Jul-25, Volume: 281, Issue:1

    Topics: Adrenergic beta-Agonists; Alanine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Function; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Enzyme Inhibitors; Guinea Pigs; Heart; Heart Atria; Heart Rate; In Vitro Techniques; Kallidin; Male; Myocardium; Nitric Oxide; Prostaglandins; Receptor, Bradykinin B2; Receptors, Bradykinin; Sensitivity and Specificity

1995
Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
    Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:6

    Topics: Alanine; Angiotensin II; Animals; Aorta, Abdominal; Arteriovenous Shunt, Surgical; Atrial Natriuretic Factor; Cyclic GMP; Diuresis; Enzyme Inhibitors; Heart Failure; Hemodynamics; Male; Natriuresis; Neprilysin; Rats; Rats, Wistar; Renin; Vena Cava, Inferior

1996